000 | 01388 a2200397 4500 | ||
---|---|---|---|
005 | 20250512203520.0 | ||
264 | 0 | _c19850531 | |
008 | 198505s 0 0 eng d | ||
022 | _a0248-4900 | ||
024 | 7 |
_a10.1111/j.1768-322x.1985.tb00342.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMartyre, M C | |
245 | 0 | 0 |
_aModulation of CALLA and HLA-DR on a non T non B leukemic cell line by lipid treatment. _h[electronic resource] |
260 |
_bBiology of the cell _c1984 |
||
300 |
_a243-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntigens, Neoplasm |
650 | 0 | 4 | _aAntigens, Surface |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Membrane _xphysiology |
650 | 0 | 4 |
_aCholesterol _xpharmacology |
650 | 0 | 4 | _aFluorescence Polarization |
650 | 0 | 4 | _aHLA-DR Antigens |
650 | 0 | 4 | _aHistocompatibility Antigens Class II |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeukemia, Lymphoid |
650 | 0 | 4 |
_aMembrane Fluidity _xdrug effects |
650 | 0 | 4 |
_aMembrane Lipids _xphysiology |
650 | 0 | 4 |
_aMembrane Proteins _ximmunology |
650 | 0 | 4 |
_aPhospholipids _xpharmacology |
700 | 1 | _aVaigot, P | |
700 | 1 | _aKayibanda, M | |
700 | 1 | _aRosenfeld, C | |
773 | 0 |
_tBiology of the cell _gvol. 52 _gno. 3 _gp. 243-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1768-322x.1985.tb00342.x _zAvailable from publisher's website |
999 |
_c6241808 _d6241808 |